
Overview
Dr. Michael Cole is a distinguished graduate of the US Air Force Academy (2006), and as an Alberta Bart Holaday Scholar went on to complete his Doctor of Philosophy in Biochemistry (2010) at University of Oxford under the direction of Prof Paul Wentworth Jr. and Prof Bob Sim. He focused his research on peptide chemistry and acyl group reactivity in thioester-containing proteins such as complement proteins, C3 and C4. He fulfilled his Air Force commitment as a chemist and Assistant Professor of Chemistry at the US Air Force Academy. He came to Johns Hopkins University for medical school in 2014. Since that time, he has stayed at Johns Hopkins completing his medical degree (2018), internal medicine residency training (2021), and hematology fellowship (2024). In 2024, he joined the Division of Hematology as an Instructor.
Dr. Cole is rated as an Experienced provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, and Atypical Hemolytic Uremic Syndrome (aHUS).
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Atypical Hemolytic Uremic Syndrome (aHUS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
4940 Eastern Avenue, Baltimore, MD 21224
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.
Johns Hopkins Outpatient Center
Dr. Shruti Chaturvedi is an Associate Professor of Medicine at Johns Hopkins. She received her medical degree from Maulana Azad Medical College, University of Delhi, India. She then completed a residency in Internal Medicine at the Cleveland Clinic, Cleveland, OH, and a fellowship in Hematology and Oncology at Vanderbilt University, Nashville, TN. She has additionally obtained a Master of Science in Clinical Investigation (MSCI) degree from Vanderbilt University. Dr. Chaturvedi specializes in the care of adults with non-malignant hematologic disorders including thrombocytopenic purpura, atypical hemolytic uremic syndrome, antiphospholpiid syndrome, immune thrombocytopenia, autoimmune hemolytic anemia, thrombotic, other bleeding and clotting disorders, and anemias. Her research is focused on improving the care of patients with thrombotic microangiopathies with a focus on long term sequelae, and the role of complement in thrombotic disorders such as the antiphospholipid syndrome. Dr. Chaturvedi is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). Her top areas of expertise are Blood Clots, Atypical Hemolytic Uremic Syndrome (aHUS), Anemia, Splenectomy, and Bone Marrow Aspiration.
Christiana Care Health Services Inc
. Dr. Rubenstein is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Familial Colorectal Cancer, Melanoma, Breast Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- D-Minus Hemolytic Uremic Syndrome
- D-Plus Hemolytic Uremic Syndrome
- Hemolytic-Uremic SyndromeDr. Cole isAdvanced. Learn about Hemolytic-Uremic Syndrome.
- Experienced
- AnemiaDr. Cole isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Cole isExperienced. Learn about Antiphospholipid Syndrome.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Hemolytic AnemiaDr. Cole isExperienced. Learn about Hemolytic Anemia.
- ThrombocytopeniaDr. Cole isExperienced. Learn about Thrombocytopenia.

